28 /100
MEDIUM RISK
Score updated Apr 13, 2026

AKTS

Aktis Oncology, Inc. — Stock Dilution Tracker

Track AKTS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

🔔 Track AKTS — Get alerts when the score changes →
📊 Score Breakdown
📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
40
⚠️ Warrant Exposure
15
🔄Convertible Debt
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for AKTS.
🔔 Track AKTS — Get forecast alerts →
💹 Market Data
Market Cap$933.06M
Shares Outstanding53.40M
Float26.39M
Cash$226.79M
Debt$11.55M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 94.2% shares (2025Q4 vs prior)
3 institutional holders · 28.8K shares
#1 Kohmann Bosshard Financial Services, LLC 27.8K shares
#2 Sarver Vrooman Wealth Advisors 1.0K shares
#3 VSM Wealth Advisory, LLC 50 shares
📉 Short Interest
Short Interest2.32M
Days to Cover3.0
% of Float8.8%
FINRA data as of Mar 31, 2026
📁 Recent SEC Activity
3 FORM3 Jan 15, 2026
4 INSIDER TRANSACTION Jan 14, 2026
4 INSIDER TRANSACTION Jan 14, 2026
4 INSIDER TRANSACTION Jan 14, 2026
4 INSIDER TRANSACTION Jan 12, 2026
Full SEC filing analysis available with free account
📰 Recent News
Track AKTS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking AKTS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required